Skip to main content Skip to navigation

The Azure Grant Program applications are open

Over the past decade, we have witnessed major advances in the fields of immunology and immune function leveraging state-of-the-art flow cytometry instrumentation and reagents. These advances in technologies have allowed us faster time to insights. Thus, enabling our understanding of disease pathogenesis and thereby development of better treatment modalities. However, many questions remain unaddressed as we try to solve the enigma of the immune system. To support our understanding of disease pathogenesis and the role of immune responses, BD is announcing the Azure 2022 Life Sciences Research Reagents Funding Initiative to fund research in areas of immuno-oncology, immune metabolism and neuroimmunology. This initiative is intended to support novel discoveries and observations that will help drive better treatment modalities and advancing the world of health™.

2022 Azure Lifesciences Research Reagents Funding Initiative Timeline
Oct. 30 through Dec. 31, 2021

Initiative will open for project proposal submissions on October 30, 2021, and will continue until sufficient applications have been received or until December 31, 2021, whichever is sooner.  

Jan. 1 through Aug. 31, 2022

Proposal evaluation / approval period. 

Awardees will be notified on a rolling basis. Awards will be subject to terms to be provided by BD. If terms are not executed within the time specified therein, BD may withdraw the award.

April 2 through Sep. 30, 2022 Funding to be issued for selected projects.